Recombinant EGFR (Panitumumab Biosimilar) anticorps

N° du produit ABIN7795086

L’anticorps Souris Monoclonal anti-EGFR (Panitumumab Biosimilar) a été validé pour FACS et in vivo. Il convient pour détecter EGFR (Panitumumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant EGFR (Panitumumab Biosimilar) anticorps (ABIN7795086)

Antigène: EGFR (Panitumumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp EGFR (Panitumumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit anti-EGFR (Panitumumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Panitumumab Biosimilar, Endotoxin 0.05 EU/mg

Attributs du produit: Panitumumab, a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS".

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: Less than 0.5 EU/mg of protein as determined by LAL method

Immunogène: Human EGFR / ErbB-1 / HER1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur EGFR (Panitumumab Biosimilar)

Antigène: EGFR (Panitumumab Biosimilar)

Autre désignation: Panitumumab Biosimilar

Classe de substances: Biosimilar